Back to Search
JEFFREY WELSCH, MD
MD
Urology Physician
NPI: 1841296092IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
44343(WI)
CMS Specialties
PrimaryUROLOGY
Education
MEDICAL COLLEGE OF WISCONSIN
Class of 1996
Research & Publications (20)
Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa.
PMID 19302008·J Infect Dis·2009
8-other
Modulation of rat pituitary growth hormone by 670 nm light.
PMID 19091612·Growth Horm IGF Res·2009
7-preclinical
Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera.
PMID 19047406·Infect Immun·2009
7-preclinical
Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity.
PMID 19339487·Clin Vaccine Immunol·2009
8-other
Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein.
PMID 18591239·Infect Immun·2008
7-preclinical
Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen.
PMID 18419542·J Infect Dis·2008
8-other
Influence of oral contraceptive use on growth hormone in vivo bioactivity following resistance exercise: responses of molecular mass variants.
PMID 18037316·Growth Horm IGF Res·2008
3-trial
Immunity to Neisseria meningitidis group B in adults despite lack of serum bactericidal antibody.
PMID 17913865·Clin Vaccine Immunol·2007
4-observational
Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson's disease.
PMID 17187291·J Neural Transm (Vienna)·2007
8-other
Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine.
PMID 17436227·J Infect Dis·2007
4-observational
Improved immunogenicity of a H44/76 group B outer membrane vesicle vaccine with over-expressed genome-derived Neisserial antigen 1870.
PMID 16677743·Vaccine·2007
7-preclinical
Role of FNR and FNR-regulated, sugar fermentation genes in Neisseria meningitidis infection.
PMID 16677307·Mol Microbiol·2006
7-preclinical
Chronic resistance training in women potentiates growth hormone in vivo bioactivity: characterization of molecular mass variants.
PMID 16835404·Am J Physiol Endocrinol Metab·2006
2-rct
A universal vaccine for serogroup B meningococcus.
PMID 16825336·Proc Natl Acad Sci U S A·2006
7-preclinical
The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.
PMID 16785547·J Immunol·2006
8-other
Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine.
PMID 16479517·J Infect Dis·2006
2-rct
Is iterative reconstruction an alternative to filtered backprojection in routine processing of dopamine transporter SPECT studies?
PMID 16269593·J Nucl Med·2005
4-observational
Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870.
PMID 16028126·J Infect Dis·2005
7-preclinical
Immunogenicity of an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine in 2-year old children.
PMID 15921829·Vaccine·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 309 LAKEVIEW DR, SUITE A
BELGIUM, WI 53004 - Phone
- (262) 285-4169
Quick Facts
- NPI
- 1841296092
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile